X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ALBO

Closed

Albireo Pharma Inc

44.15
0.00 (0.00%)
Last Update: 03 Mar 2023 00:00:00
Yesterday: 44.15
Day's Range: 0. - 0.
Send
When Written:
 
44.15
Albireo Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing therapies for rare pediatric liver diseases and other liver-related disorders. The company's lead product candidate, odevixibat, is an oral medication designed to treat progressive familial intrahepatic cholestasis (PFIC), a rare genetic disorder that affects the liver. Albireo Pharma also has other pipeline candidates in development, including A3907, a treatment for nonalcoholic steatohepatitis (NASH). The company was founded in 2008 and is headquartered in Boston, Massachusetts. It is publicly traded on the NASDAQ under the ticker symbol ALBO.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X